Related Experiment Video
Updated: Jul 15, 2026

Real-Time Polymerase Chain Reaction-Based Detection and Quantification of Hepatitis B Virus DNA
Published on: December 15, 2023
Relationship between hepatitis B virus DNA levels and liver histology in patients with chronic hepatitis B
1Department of Hepatic Disease, People's Hospital, Peking University, Beijing 100034, China. shaoj21@163.com
Insights
Hepatitis B virus (HBV) DNA levels do not correlate with liver damage in chronic hepatitis B (CHB) patients. Hepatitis B e antigen (HBeAg)-negative patients are older with lower HBV DNA and longer infection history.
Area of Science:
- Hepatology
- Virology
- Gastroenterology
Background:
- Chronic hepatitis B (CHB) is a significant global health concern.
- Understanding the relationship between viral load and liver damage is crucial for patient management.
Purpose of the Study:
- To investigate the correlation between hepatitis B virus (HBV) DNA levels and liver histology in CHB patients.
- To determine the prevalence and characteristics of hepatitis B e antigen (HBeAg)-negative CHB patients.
Main Methods:
- Serum HBV DNA levels were quantified in 213 CHB patients using the COBAS Amplicor HBV Monitor test.
- Patients were stratified into HBeAg-positive and HBeAg-negative groups.
- Correlations between HBV DNA levels, liver histology, and biochemical markers were analyzed.
Main Results:
- No correlation was found between HBV DNA levels and histological grade or stage of liver disease in either HBeAg-positive or HBeAg-negative patients.
- HBeAg-negative patients were older, had a longer history of HBV infection, and lower HBV DNA levels compared to HBeAg-positive patients.
- While HBV DNA correlated with ALT in HBeAg-negative patients, no significant correlations were observed with AST in this group or with ALT/AST in HBeAg-positive patients.
Conclusions:
- Serum HBV DNA levels do not reliably predict liver histology in CHB patients with high viral loads (>10^5 copies/mL).
- HBeAg-negative CHB patients exhibit distinct demographic and virologic characteristics, including older age, longer infection duration, and lower viral loads.
- Liver histology and standard liver enzymes (ALT, AST) showed no significant differences between HBeAg-positive and HBeAg-negative patient groups.
Aim:
To study the relationship between hepatitis B virus (HBV) DNA levels and liver histology in patients with chronic hepatitis B (CHB) and to determine the prevalence and characteristics of hepatitis B e antigen (HBeAg) negative patients.
Methods:
A total of 213 patients with CHB were studied, and serum HBV DNA levels were measured by the COBAS Amplicor HBV Monitor test. All patients were divided into two groups according to the HBeAg status. The correlation between serum HBV DNA levels and liver damage (liver histology and biochemistry) was explored.
Results:
Of the 213 patients with serum HBV DNA levels higher than 10(5) copies/mL, 178 (83.6%) were HBeAg positive, 35 (16.4%) were HBeAg negative. The serum HBV DNA levels were not correlated to the age, history of CHB, histological grade and stage of liver disease in either HBeAg negative or HBeAg positive patients. There was no correlation between serum levels of HBV DNA and alanine aminotransferanse (ALT), aspartate aminotransferase (AST) in HBeAg positive patients. In HBeAg negative patients, there was no correlation between serum levels of HBV DNA and AST, while serum DNA levels correlated with ALT (r=0.351, P=0.042). The grade (G) of liver disease correlated with ALT and AST (P<0.05, r=0.205, 0.327 respectively) in HBeAg positive patients. In HBeAg negative patients, correlations were shown between ALT, AST and the G (P<0.01, and r=0.862, 0.802 respectively). HBeAg negative patients were older (35 +/- 9 years vs 30 +/- 9 years, P<0.05 ) and had a longer history of HBV infection (8 +/- 4 years vs 6 +/- 4 years, P<0.05) and a lower HBV DNA level than HBeAg positive patients (8.4 +/- 1.7 Log HBV DNA vs 9.8 +/- 1.3 Log HBV DNA, P<0.001). There were no significant differences in sex ratio, ALT and AST levels and liver histology between the two groups.
Conclusion:
Serum HBV DNA level is not correlated to histological grade or stage of liver disease in CHB patients with HBV DNA more than 10(5) copies/mL. Compared to HBeAg positive patients, HBeAg negative patients are older and have a lower HBV DNA level and a longer HBV infection history. There is no significant difference in sex ratio, ALT and AST levels and liver histology between the two groups.
Related Concept Videos
Hepatitis
Viral Hepatitis I: Introduction
Cirrhosis I: Introduction
Cirrhosis II: Pathophysiology
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
Liver Histology
Hepatocytes perform a variety of essential functions. They secrete...

